Current investigations focusing on these novel small protein chains, a unique class of compounds exhibiting considerable capability for targeting multiple disease pathways. Distinct from existing small molecule methods, Nexaph peptides offer improved selectivity and lesser off-target consequences, making them a highly encouraging option for next-ge